Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Blagosklonny

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Leukemia|December 22, 1999
Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversalM V Blagosklonny
Leukemia|February 24, 2001
The dilemma of apoptosis in myelodysplasia and leukemia: a new promise of therapeutic intervention?M V Blagosklonny
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2000
p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effectM V Blagosklonny
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 13, 2001
Paradox of Bcl-2 (and p53): why may apoptosis-regulating proteins be irrelevant to cell death?M V Blagosklonny
Leukemia|April 18, 2002
Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogsM V Blagosklonny
Leukemia|April 18, 2002
STI-571 must select for drug-resistant cells but 'no cell breathes fire out of its nostrils like a dragon'M V Blagosklonny
Cell Death & Disease|December 6, 2014
Koschei the immortal and anti-aging drugsM V Blagosklonny
Cell Death & Disease|December 17, 2013
TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologistsM V Blagosklonny
Cell Death and Differentiation|April 9, 2005
Carcinogenesis, cancer therapy and chemopreventionM V Blagosklonny
British Journal of Cancer|October 2, 2003
Tissue-selective therapy of cancerM V Blagosklonny
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Leukemia|December 22, 1999
Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversalM V Blagosklonny
Leukemia|February 24, 2001
The dilemma of apoptosis in myelodysplasia and leukemia: a new promise of therapeutic intervention?M V Blagosklonny
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2000
p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effectM V Blagosklonny
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 13, 2001
Paradox of Bcl-2 (and p53): why may apoptosis-regulating proteins be irrelevant to cell death?M V Blagosklonny
Leukemia|April 18, 2002
Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogsM V Blagosklonny
Leukemia|April 18, 2002
STI-571 must select for drug-resistant cells but 'no cell breathes fire out of its nostrils like a dragon'M V Blagosklonny
Cell Death & Disease|December 6, 2014
Koschei the immortal and anti-aging drugsM V Blagosklonny
Cell Death & Disease|December 17, 2013
TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologistsM V Blagosklonny
Cell Death and Differentiation|April 9, 2005
Carcinogenesis, cancer therapy and chemopreventionM V Blagosklonny
British Journal of Cancer|October 2, 2003
Tissue-selective therapy of cancerM V Blagosklonny
Pageof 9